Author

John Jeang

Observed name: John A Jeang

Institutions: Broad Institute, Tufts University, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Observed institutions: Broad Institute, Tufts University, University of Alabama at Birmingham, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, UAB Medicine

OpenAlex ID: A5089935076

Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis

2024 · Eric W Prince, John R Apps, et al. · Neuro-Oncology · 39

A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

2025 · Veronica Rendo, Eudocia Q. Lee, et al. · Science Translational Medicine · 17

A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

2025 · April A. Apfelbaum, Eric Morin, et al. · Nature Communications · 13

A diverse landscape of FGFR alterations and co-mutations defines novel therapeutic strategies in pediatric low-grade gliomas

2024 · Eric Morin, April A. Apfelbaum, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4

LGG-58. Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology

2022 · Michelle Boisvert, Ashwyn A Perera, et al. · Neuro-Oncology · 2

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

2025 · April A. Apfelbaum, Eric Morin, et al. · Nature Communications

Abstract B009: Cancer-associated fibroblasts remodel the extracellular matrix in Adamantinomatous Craniopharyngioma

2025 · Timothy H Chang, Shriya M Rangaswamy, et al. · Cancer Research

Abstract A014: Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology

2025 · Michelle Boisvert, Ashwyn Perera, et al. · Cancer Research

Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma

2024 · Veronica Rendo, Eudocia Q. Lee, et al. · medRxiv

Lgg-11. Understanding the Transcriptional Heterogeneity of Pediatric Low-grade Gliomas and Its Implication for Tumor Pathophysiology

2024 · Michelle Boisvert, Ashwyn A Perera, et al. · Neuro-Oncology

Cp-03. Extracellular Matrix Remodeling Reveals Non-cell Autonomous Tumor Formation Mechanism in Adamantinomatous Craniopharyngiomas

2024 · John A Jeang, Danny Jomaa, et al. · Neuro-Oncology

Works count: 11

Citation count: 75

H-index: 4

I10-index: 3